Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Find Clinical Drug Pipeline Developments & Deals by Spiral Therapeutics

Spiral Therapeutics

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

Developments

Filters

×

FILTER:

filter

Company

filter

Sponsor

filter

Country

filter

Therapeutic Area

filter

Study Phase

Active Filter(s):

Filters

Reset Filter

All Developments

Companies By Therapeutic Area

Development Status

Spiral Therapeutics

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Meniere's Disease

Details:

SPT-2101 is a sustained-release steroid formulation designed for precise inner ear administration using Spiral's novel delivery procedure. Spiral recently completed enrollment of an open label pilot clinical study of SPT-2101 in 10 patients with Meniere's disease.

Lead Product(s): SPT-2101

Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Product Name: SPT-2101

Highest Development Status: Phase I Product Type: Small molecule

Partner/Sponsor/Collaborator: Savoir Capital

Deal Size: $8.2 million Upfront Cash: Undisclosed

Deal Type: Financing January 10, 2023

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY